Huo et al reported the MESO index for evaluating a patient with hepatic cirrhosis. This can help to identify a patient with a poor prognosis.The authors are from National Yang-Ming University and Taipei Veterans General Hospital in Taiwan.
Patient selection: hepatic cirrhosis
Outcome: 3-month mortality
Parameters:
(1) modified MELD score (original x10)
(2) serum sodium concentration in mmol/L (mEq/L)
MESO index =
= (MELD) / (serum sodium) * 10
Interpretation:
• The higher the MESO index the worse the survival.
Parameter
Risk Group
50% Mortality
< 0.8
low
85 months
0.8 to 1.6
intermediate
30.3 months
> 1.6
high
1.5 months
Performance:
• A MESO index > 1.6 is 50% sensitive and 97% specific for 3-month mortality.
